Dyne Therapeutics
Stock Forecast, Prediction & Price Target

Dyne Therapeutics Financial Estimates

Dyne Therapeutics Revenue Estimates

Dyne Therapeutics EBITDA Estimates

Dyne Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $14.69M
Low: $14.69M
High: $14.69M
avg. 0%
Avg: $57.80M
Low: $57.80M
High: $57.80M
avg. 293.25%
Avg: $264.19M
Low: $264.19M
High: $264.19M
avg. 357.06%
Avg: $643.86M
Low: $643.86M
High: $643.86M
avg. 143.70%
Net Income
 
% change YoY
$-149.28M
 
N/A
$-165.23M
 
-10.68%
$-235.93M
 
-42.78%
Avg: $-294.02M
Low: $-238.13M
High: $-84.15M
avg. -24.62%
Avg: $-275.85M
Low: $-241.71M
High: $13.72M
avg. 6.18%
Avg: $-72.21M
Low: $-72.21M
High: $-72.21M
avg. 73.82%
Avg: $65.65M
Low: $65.65M
High: $65.65M
avg. 190.90%
EBITDA
 
% change YoY
$-148.20M
 
N/A
$-170.96M
 
-15.35%
$-233.47M
 
-36.56%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$2.93
 
N/A
-$3.18
 
-8.53%
-$3.95
 
-24.21%
Avg: -$3.07
Low: -$3.99
High: -$1.41
avg. 22.34%
Avg: -$2.72
Low: -$4.05
High: $0.23
avg. 11.39%
Avg: -$1.21
Low: -$1.21
High: -$1.21
avg. 55.47%
Avg: $1.1
Low: $1.1
High: $1.1
avg. 190.90%
Operating Expenses
 
% change YoY
$150.02M
 
N/A
$170.96M
 
13.95%
$242.16M
 
41.64%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Dyne Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 61.57% in 2025-2028.

We have gathered data from 9 analysts. Their low estimate is -238.13M, average is -294.02M and high is -84.15M.

What is Dyne Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 198.50% in 2025-2028.

We have gathered data from 6 analysts. Their low revenue estimate is $14.69M, average is $14.69M and high is $14.69M.

What is Dyne Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 70.03% in 2025-2028.

We have gathered data from 9 analysts. Their low earnings per share estimate is -$3.99, average is -$3.07 and high is $-1.41.

What is the best performing analyst?

In the last twelve months analysts have been covering Dyne Therapeutics stock. The most successful analyst is Eun Yang.